Global Trastuzumab Biosimilar Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
LPI (LP Information)' newest research report, the “Trastuzumab Biosimilar Industry Forecast” looks at past sales and reviews total world Trastuzumab Biosimilar sales in 2022, providing a comprehensive analysis by region and market sector of projected Trastuzumab Biosimilar sales for 2023 through 2029. With Trastuzumab Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Trastuzumab Biosimilar industry.
This Insight Report provides a comprehensive analysis of the global Trastuzumab Biosimilar landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Trastuzumab Biosimilar portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Trastuzumab Biosimilar market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Trastuzumab Biosimilar and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Trastuzumab Biosimilar.
The global Trastuzumab Biosimilar market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
This report presents a comprehensive overview, market shares, and growth opportunities of Trastuzumab Biosimilar market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Trastuzumab Biosimilar market?
What factors are driving Trastuzumab Biosimilar market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Trastuzumab Biosimilar market opportunities vary by end market size?
How does Trastuzumab Biosimilar break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
LPI (LP Information)' newest research report, the “Trastuzumab Biosimilar Industry Forecast” looks at past sales and reviews total world Trastuzumab Biosimilar sales in 2022, providing a comprehensive analysis by region and market sector of projected Trastuzumab Biosimilar sales for 2023 through 2029. With Trastuzumab Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Trastuzumab Biosimilar industry.
This Insight Report provides a comprehensive analysis of the global Trastuzumab Biosimilar landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Trastuzumab Biosimilar portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Trastuzumab Biosimilar market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Trastuzumab Biosimilar and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Trastuzumab Biosimilar.
The global Trastuzumab Biosimilar market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor.
This report presents a comprehensive overview, market shares, and growth opportunities of Trastuzumab Biosimilar market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Adjuvant Breast Cancer
- Metastatic Breast Cancer
- Metastatic Gastric Cancer
- Others
- Hospital Pharmacy
- Online Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- Pfizer Inc
- Samsung Bioepis
- Merck & Co.
- Biocon Limited
- Teva Pharmaceutical
- Genentech
- Mundipharma
- Celltrion
- Henlius
What is the 10-year outlook for the global Trastuzumab Biosimilar market?
What factors are driving Trastuzumab Biosimilar market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Trastuzumab Biosimilar market opportunities vary by end market size?
How does Trastuzumab Biosimilar break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Trastuzumab Biosimilar Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Trastuzumab Biosimilar by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Trastuzumab Biosimilar by Country/Region, 2018, 2022 & 2029
2.2 Trastuzumab Biosimilar Segment by Type
2.2.1 Adjuvant Breast Cancer
2.2.2 Metastatic Breast Cancer
2.2.3 Metastatic Gastric Cancer
2.2.4 Others
2.3 Trastuzumab Biosimilar Sales by Type
2.3.1 Global Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
2.3.2 Global Trastuzumab Biosimilar Revenue and Market Share by Type (2018-2023)
2.3.3 Global Trastuzumab Biosimilar Sale Price by Type (2018-2023)
2.4 Trastuzumab Biosimilar Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Pharmacy
2.5 Trastuzumab Biosimilar Sales by Application
2.5.1 Global Trastuzumab Biosimilar Sale Market Share by Application (2018-2023)
2.5.2 Global Trastuzumab Biosimilar Revenue and Market Share by Application (2018-2023)
2.5.3 Global Trastuzumab Biosimilar Sale Price by Application (2018-2023)
3 GLOBAL TRASTUZUMAB BIOSIMILAR BY COMPANY
3.1 Global Trastuzumab Biosimilar Breakdown Data by Company
3.1.1 Global Trastuzumab Biosimilar Annual Sales by Company (2018-2023)
3.1.2 Global Trastuzumab Biosimilar Sales Market Share by Company (2018-2023)
3.2 Global Trastuzumab Biosimilar Annual Revenue by Company (2018-2023)
3.2.1 Global Trastuzumab Biosimilar Revenue by Company (2018-2023)
3.2.2 Global Trastuzumab Biosimilar Revenue Market Share by Company (2018-2023)
3.3 Global Trastuzumab Biosimilar Sale Price by Company
3.4 Key Manufacturers Trastuzumab Biosimilar Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Trastuzumab Biosimilar Product Location Distribution
3.4.2 Players Trastuzumab Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TRASTUZUMAB BIOSIMILAR BY GEOGRAPHIC REGION
4.1 World Historic Trastuzumab Biosimilar Market Size by Geographic Region (2018-2023)
4.1.1 Global Trastuzumab Biosimilar Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Trastuzumab Biosimilar Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Trastuzumab Biosimilar Market Size by Country/Region (2018-2023)
4.2.1 Global Trastuzumab Biosimilar Annual Sales by Country/Region (2018-2023)
4.2.2 Global Trastuzumab Biosimilar Annual Revenue by Country/Region (2018-2023)
4.3 Americas Trastuzumab Biosimilar Sales Growth
4.4 APAC Trastuzumab Biosimilar Sales Growth
4.5 Europe Trastuzumab Biosimilar Sales Growth
4.6 Middle East & Africa Trastuzumab Biosimilar Sales Growth
5 AMERICAS
5.1 Americas Trastuzumab Biosimilar Sales by Country
5.1.1 Americas Trastuzumab Biosimilar Sales by Country (2018-2023)
5.1.2 Americas Trastuzumab Biosimilar Revenue by Country (2018-2023)
5.2 Americas Trastuzumab Biosimilar Sales by Type
5.3 Americas Trastuzumab Biosimilar Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Trastuzumab Biosimilar Sales by Region
6.1.1 APAC Trastuzumab Biosimilar Sales by Region (2018-2023)
6.1.2 APAC Trastuzumab Biosimilar Revenue by Region (2018-2023)
6.2 APAC Trastuzumab Biosimilar Sales by Type
6.3 APAC Trastuzumab Biosimilar Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Trastuzumab Biosimilar by Country
7.1.1 Europe Trastuzumab Biosimilar Sales by Country (2018-2023)
7.1.2 Europe Trastuzumab Biosimilar Revenue by Country (2018-2023)
7.2 Europe Trastuzumab Biosimilar Sales by Type
7.3 Europe Trastuzumab Biosimilar Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Trastuzumab Biosimilar by Country
8.1.1 Middle East & Africa Trastuzumab Biosimilar Sales by Country (2018-2023)
8.1.2 Middle East & Africa Trastuzumab Biosimilar Revenue by Country (2018-2023)
8.2 Middle East & Africa Trastuzumab Biosimilar Sales by Type
8.3 Middle East & Africa Trastuzumab Biosimilar Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Trastuzumab Biosimilar
10.3 Manufacturing Process Analysis of Trastuzumab Biosimilar
10.4 Industry Chain Structure of Trastuzumab Biosimilar
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Trastuzumab Biosimilar Distributors
11.3 Trastuzumab Biosimilar Customer
12 WORLD FORECAST REVIEW FOR TRASTUZUMAB BIOSIMILAR BY GEOGRAPHIC REGION
12.1 Global Trastuzumab Biosimilar Market Size Forecast by Region
12.1.1 Global Trastuzumab Biosimilar Forecast by Region (2024-2029)
12.1.2 Global Trastuzumab Biosimilar Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Trastuzumab Biosimilar Forecast by Type
12.7 Global Trastuzumab Biosimilar Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. Trastuzumab Biosimilar Product Portfolios and Specifications
13.1.3 Amgen Inc. Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 Pfizer Inc
13.2.1 Pfizer Inc Company Information
13.2.2 Pfizer Inc Trastuzumab Biosimilar Product Portfolios and Specifications
13.2.3 Pfizer Inc Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Inc Main Business Overview
13.2.5 Pfizer Inc Latest Developments
13.3 Samsung Bioepis
13.3.1 Samsung Bioepis Company Information
13.3.2 Samsung Bioepis Trastuzumab Biosimilar Product Portfolios and Specifications
13.3.3 Samsung Bioepis Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Samsung Bioepis Main Business Overview
13.3.5 Samsung Bioepis Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. Trastuzumab Biosimilar Product Portfolios and Specifications
13.4.3 Merck & Co. Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Biocon Limited
13.5.1 Biocon Limited Company Information
13.5.2 Biocon Limited Trastuzumab Biosimilar Product Portfolios and Specifications
13.5.3 Biocon Limited Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biocon Limited Main Business Overview
13.5.5 Biocon Limited Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Trastuzumab Biosimilar Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Genentech
13.7.1 Genentech Company Information
13.7.2 Genentech Trastuzumab Biosimilar Product Portfolios and Specifications
13.7.3 Genentech Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Genentech Main Business Overview
13.7.5 Genentech Latest Developments
13.8 Mundipharma
13.8.1 Mundipharma Company Information
13.8.2 Mundipharma Trastuzumab Biosimilar Product Portfolios and Specifications
13.8.3 Mundipharma Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mundipharma Main Business Overview
13.8.5 Mundipharma Latest Developments
13.9 Celltrion
13.9.1 Celltrion Company Information
13.9.2 Celltrion Trastuzumab Biosimilar Product Portfolios and Specifications
13.9.3 Celltrion Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Celltrion Main Business Overview
13.9.5 Celltrion Latest Developments
13.10 Henlius
13.10.1 Henlius Company Information
13.10.2 Henlius Trastuzumab Biosimilar Product Portfolios and Specifications
13.10.3 Henlius Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Henlius Main Business Overview
13.10.5 Henlius Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Trastuzumab Biosimilar Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Trastuzumab Biosimilar by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Trastuzumab Biosimilar by Country/Region, 2018, 2022 & 2029
2.2 Trastuzumab Biosimilar Segment by Type
2.2.1 Adjuvant Breast Cancer
2.2.2 Metastatic Breast Cancer
2.2.3 Metastatic Gastric Cancer
2.2.4 Others
2.3 Trastuzumab Biosimilar Sales by Type
2.3.1 Global Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
2.3.2 Global Trastuzumab Biosimilar Revenue and Market Share by Type (2018-2023)
2.3.3 Global Trastuzumab Biosimilar Sale Price by Type (2018-2023)
2.4 Trastuzumab Biosimilar Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Pharmacy
2.5 Trastuzumab Biosimilar Sales by Application
2.5.1 Global Trastuzumab Biosimilar Sale Market Share by Application (2018-2023)
2.5.2 Global Trastuzumab Biosimilar Revenue and Market Share by Application (2018-2023)
2.5.3 Global Trastuzumab Biosimilar Sale Price by Application (2018-2023)
3 GLOBAL TRASTUZUMAB BIOSIMILAR BY COMPANY
3.1 Global Trastuzumab Biosimilar Breakdown Data by Company
3.1.1 Global Trastuzumab Biosimilar Annual Sales by Company (2018-2023)
3.1.2 Global Trastuzumab Biosimilar Sales Market Share by Company (2018-2023)
3.2 Global Trastuzumab Biosimilar Annual Revenue by Company (2018-2023)
3.2.1 Global Trastuzumab Biosimilar Revenue by Company (2018-2023)
3.2.2 Global Trastuzumab Biosimilar Revenue Market Share by Company (2018-2023)
3.3 Global Trastuzumab Biosimilar Sale Price by Company
3.4 Key Manufacturers Trastuzumab Biosimilar Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Trastuzumab Biosimilar Product Location Distribution
3.4.2 Players Trastuzumab Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR TRASTUZUMAB BIOSIMILAR BY GEOGRAPHIC REGION
4.1 World Historic Trastuzumab Biosimilar Market Size by Geographic Region (2018-2023)
4.1.1 Global Trastuzumab Biosimilar Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Trastuzumab Biosimilar Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Trastuzumab Biosimilar Market Size by Country/Region (2018-2023)
4.2.1 Global Trastuzumab Biosimilar Annual Sales by Country/Region (2018-2023)
4.2.2 Global Trastuzumab Biosimilar Annual Revenue by Country/Region (2018-2023)
4.3 Americas Trastuzumab Biosimilar Sales Growth
4.4 APAC Trastuzumab Biosimilar Sales Growth
4.5 Europe Trastuzumab Biosimilar Sales Growth
4.6 Middle East & Africa Trastuzumab Biosimilar Sales Growth
5 AMERICAS
5.1 Americas Trastuzumab Biosimilar Sales by Country
5.1.1 Americas Trastuzumab Biosimilar Sales by Country (2018-2023)
5.1.2 Americas Trastuzumab Biosimilar Revenue by Country (2018-2023)
5.2 Americas Trastuzumab Biosimilar Sales by Type
5.3 Americas Trastuzumab Biosimilar Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Trastuzumab Biosimilar Sales by Region
6.1.1 APAC Trastuzumab Biosimilar Sales by Region (2018-2023)
6.1.2 APAC Trastuzumab Biosimilar Revenue by Region (2018-2023)
6.2 APAC Trastuzumab Biosimilar Sales by Type
6.3 APAC Trastuzumab Biosimilar Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Trastuzumab Biosimilar by Country
7.1.1 Europe Trastuzumab Biosimilar Sales by Country (2018-2023)
7.1.2 Europe Trastuzumab Biosimilar Revenue by Country (2018-2023)
7.2 Europe Trastuzumab Biosimilar Sales by Type
7.3 Europe Trastuzumab Biosimilar Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Trastuzumab Biosimilar by Country
8.1.1 Middle East & Africa Trastuzumab Biosimilar Sales by Country (2018-2023)
8.1.2 Middle East & Africa Trastuzumab Biosimilar Revenue by Country (2018-2023)
8.2 Middle East & Africa Trastuzumab Biosimilar Sales by Type
8.3 Middle East & Africa Trastuzumab Biosimilar Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Trastuzumab Biosimilar
10.3 Manufacturing Process Analysis of Trastuzumab Biosimilar
10.4 Industry Chain Structure of Trastuzumab Biosimilar
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Trastuzumab Biosimilar Distributors
11.3 Trastuzumab Biosimilar Customer
12 WORLD FORECAST REVIEW FOR TRASTUZUMAB BIOSIMILAR BY GEOGRAPHIC REGION
12.1 Global Trastuzumab Biosimilar Market Size Forecast by Region
12.1.1 Global Trastuzumab Biosimilar Forecast by Region (2024-2029)
12.1.2 Global Trastuzumab Biosimilar Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Trastuzumab Biosimilar Forecast by Type
12.7 Global Trastuzumab Biosimilar Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Information
13.1.2 Amgen Inc. Trastuzumab Biosimilar Product Portfolios and Specifications
13.1.3 Amgen Inc. Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Amgen Inc. Main Business Overview
13.1.5 Amgen Inc. Latest Developments
13.2 Pfizer Inc
13.2.1 Pfizer Inc Company Information
13.2.2 Pfizer Inc Trastuzumab Biosimilar Product Portfolios and Specifications
13.2.3 Pfizer Inc Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Inc Main Business Overview
13.2.5 Pfizer Inc Latest Developments
13.3 Samsung Bioepis
13.3.1 Samsung Bioepis Company Information
13.3.2 Samsung Bioepis Trastuzumab Biosimilar Product Portfolios and Specifications
13.3.3 Samsung Bioepis Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Samsung Bioepis Main Business Overview
13.3.5 Samsung Bioepis Latest Developments
13.4 Merck & Co.
13.4.1 Merck & Co. Company Information
13.4.2 Merck & Co. Trastuzumab Biosimilar Product Portfolios and Specifications
13.4.3 Merck & Co. Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck & Co. Main Business Overview
13.4.5 Merck & Co. Latest Developments
13.5 Biocon Limited
13.5.1 Biocon Limited Company Information
13.5.2 Biocon Limited Trastuzumab Biosimilar Product Portfolios and Specifications
13.5.3 Biocon Limited Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biocon Limited Main Business Overview
13.5.5 Biocon Limited Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Trastuzumab Biosimilar Product Portfolios and Specifications
13.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Genentech
13.7.1 Genentech Company Information
13.7.2 Genentech Trastuzumab Biosimilar Product Portfolios and Specifications
13.7.3 Genentech Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Genentech Main Business Overview
13.7.5 Genentech Latest Developments
13.8 Mundipharma
13.8.1 Mundipharma Company Information
13.8.2 Mundipharma Trastuzumab Biosimilar Product Portfolios and Specifications
13.8.3 Mundipharma Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mundipharma Main Business Overview
13.8.5 Mundipharma Latest Developments
13.9 Celltrion
13.9.1 Celltrion Company Information
13.9.2 Celltrion Trastuzumab Biosimilar Product Portfolios and Specifications
13.9.3 Celltrion Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Celltrion Main Business Overview
13.9.5 Celltrion Latest Developments
13.10 Henlius
13.10.1 Henlius Company Information
13.10.2 Henlius Trastuzumab Biosimilar Product Portfolios and Specifications
13.10.3 Henlius Trastuzumab Biosimilar Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Henlius Main Business Overview
13.10.5 Henlius Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Trastuzumab Biosimilar Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Trastuzumab Biosimilar Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adjuvant Breast Cancer
Table 4. Major Players of Metastatic Breast Cancer
Table 5. Major Players of Metastatic Gastric Cancer
Table 6. Major Players of Others
Table 7. Global Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 8. Global Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Table 9. Global Trastuzumab Biosimilar Revenue by Type (2018-2023) & ($ million)
Table 10. Global Trastuzumab Biosimilar Revenue Market Share by Type (2018-2023)
Table 11. Global Trastuzumab Biosimilar Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 13. Global Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Table 14. Global Trastuzumab Biosimilar Revenue by Application (2018-2023)
Table 15. Global Trastuzumab Biosimilar Revenue Market Share by Application (2018-2023)
Table 16. Global Trastuzumab Biosimilar Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Trastuzumab Biosimilar Sales by Company (2018-2023) & (K Units)
Table 18. Global Trastuzumab Biosimilar Sales Market Share by Company (2018-2023)
Table 19. Global Trastuzumab Biosimilar Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Trastuzumab Biosimilar Revenue Market Share by Company (2018-2023)
Table 21. Global Trastuzumab Biosimilar Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Trastuzumab Biosimilar Producing Area Distribution and Sales Area
Table 23. Players Trastuzumab Biosimilar Products Offered
Table 24. Trastuzumab Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Trastuzumab Biosimilar Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Trastuzumab Biosimilar Sales Market Share Geographic Region (2018-2023)
Table 29. Global Trastuzumab Biosimilar Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Trastuzumab Biosimilar Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Trastuzumab Biosimilar Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Trastuzumab Biosimilar Sales Market Share by Country/Region (2018-2023)
Table 33. Global Trastuzumab Biosimilar Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Trastuzumab Biosimilar Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Trastuzumab Biosimilar Sales by Country (2018-2023) & (K Units)
Table 36. Americas Trastuzumab Biosimilar Sales Market Share by Country (2018-2023)
Table 37. Americas Trastuzumab Biosimilar Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Trastuzumab Biosimilar Revenue Market Share by Country (2018-2023)
Table 39. Americas Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 40. Americas Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 41. APAC Trastuzumab Biosimilar Sales by Region (2018-2023) & (K Units)
Table 42. APAC Trastuzumab Biosimilar Sales Market Share by Region (2018-2023)
Table 43. APAC Trastuzumab Biosimilar Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Trastuzumab Biosimilar Revenue Market Share by Region (2018-2023)
Table 45. APAC Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 46. APAC Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 47. Europe Trastuzumab Biosimilar Sales by Country (2018-2023) & (K Units)
Table 48. Europe Trastuzumab Biosimilar Sales Market Share by Country (2018-2023)
Table 49. Europe Trastuzumab Biosimilar Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Trastuzumab Biosimilar Revenue Market Share by Country (2018-2023)
Table 51. Europe Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 52. Europe Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Trastuzumab Biosimilar Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Trastuzumab Biosimilar Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Trastuzumab Biosimilar Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Trastuzumab Biosimilar
Table 60. Key Market Challenges & Risks of Trastuzumab Biosimilar
Table 61. Key Industry Trends of Trastuzumab Biosimilar
Table 62. Trastuzumab Biosimilar Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Trastuzumab Biosimilar Distributors List
Table 65. Trastuzumab Biosimilar Customer List
Table 66. Global Trastuzumab Biosimilar Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Trastuzumab Biosimilar Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Trastuzumab Biosimilar Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Trastuzumab Biosimilar Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Trastuzumab Biosimilar Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Trastuzumab Biosimilar Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Trastuzumab Biosimilar Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Trastuzumab Biosimilar Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Trastuzumab Biosimilar Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Trastuzumab Biosimilar Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Trastuzumab Biosimilar Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Trastuzumab Biosimilar Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Trastuzumab Biosimilar Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Trastuzumab Biosimilar Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Amgen Inc. Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Inc. Trastuzumab Biosimilar Product Portfolios and Specifications
Table 82. Amgen Inc. Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Amgen Inc. Main Business
Table 84. Amgen Inc. Latest Developments
Table 85. Pfizer Inc Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Inc Trastuzumab Biosimilar Product Portfolios and Specifications
Table 87. Pfizer Inc Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Pfizer Inc Main Business
Table 89. Pfizer Inc Latest Developments
Table 90. Samsung Bioepis Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 91. Samsung Bioepis Trastuzumab Biosimilar Product Portfolios and Specifications
Table 92. Samsung Bioepis Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Samsung Bioepis Main Business
Table 94. Samsung Bioepis Latest Developments
Table 95. Merck & Co. Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck & Co. Trastuzumab Biosimilar Product Portfolios and Specifications
Table 97. Merck & Co. Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Merck & Co. Main Business
Table 99. Merck & Co. Latest Developments
Table 100. Biocon Limited Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 101. Biocon Limited Trastuzumab Biosimilar Product Portfolios and Specifications
Table 102. Biocon Limited Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Biocon Limited Main Business
Table 104. Biocon Limited Latest Developments
Table 105. Teva Pharmaceutical Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Trastuzumab Biosimilar Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Main Business
Table 109. Teva Pharmaceutical Latest Developments
Table 110. Genentech Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 111. Genentech Trastuzumab Biosimilar Product Portfolios and Specifications
Table 112. Genentech Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Genentech Main Business
Table 114. Genentech Latest Developments
Table 115. Mundipharma Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 116. Mundipharma Trastuzumab Biosimilar Product Portfolios and Specifications
Table 117. Mundipharma Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Mundipharma Main Business
Table 119. Mundipharma Latest Developments
Table 120. Celltrion Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 121. Celltrion Trastuzumab Biosimilar Product Portfolios and Specifications
Table 122. Celltrion Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Celltrion Main Business
Table 124. Celltrion Latest Developments
Table 125. Henlius Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 126. Henlius Trastuzumab Biosimilar Product Portfolios and Specifications
Table 127. Henlius Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Henlius Main Business
Table 129. Henlius Latest Developments
Table 1. Trastuzumab Biosimilar Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Trastuzumab Biosimilar Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Adjuvant Breast Cancer
Table 4. Major Players of Metastatic Breast Cancer
Table 5. Major Players of Metastatic Gastric Cancer
Table 6. Major Players of Others
Table 7. Global Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 8. Global Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Table 9. Global Trastuzumab Biosimilar Revenue by Type (2018-2023) & ($ million)
Table 10. Global Trastuzumab Biosimilar Revenue Market Share by Type (2018-2023)
Table 11. Global Trastuzumab Biosimilar Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 13. Global Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Table 14. Global Trastuzumab Biosimilar Revenue by Application (2018-2023)
Table 15. Global Trastuzumab Biosimilar Revenue Market Share by Application (2018-2023)
Table 16. Global Trastuzumab Biosimilar Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Trastuzumab Biosimilar Sales by Company (2018-2023) & (K Units)
Table 18. Global Trastuzumab Biosimilar Sales Market Share by Company (2018-2023)
Table 19. Global Trastuzumab Biosimilar Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Trastuzumab Biosimilar Revenue Market Share by Company (2018-2023)
Table 21. Global Trastuzumab Biosimilar Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Trastuzumab Biosimilar Producing Area Distribution and Sales Area
Table 23. Players Trastuzumab Biosimilar Products Offered
Table 24. Trastuzumab Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Trastuzumab Biosimilar Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Trastuzumab Biosimilar Sales Market Share Geographic Region (2018-2023)
Table 29. Global Trastuzumab Biosimilar Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Trastuzumab Biosimilar Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Trastuzumab Biosimilar Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Trastuzumab Biosimilar Sales Market Share by Country/Region (2018-2023)
Table 33. Global Trastuzumab Biosimilar Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Trastuzumab Biosimilar Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Trastuzumab Biosimilar Sales by Country (2018-2023) & (K Units)
Table 36. Americas Trastuzumab Biosimilar Sales Market Share by Country (2018-2023)
Table 37. Americas Trastuzumab Biosimilar Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Trastuzumab Biosimilar Revenue Market Share by Country (2018-2023)
Table 39. Americas Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 40. Americas Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 41. APAC Trastuzumab Biosimilar Sales by Region (2018-2023) & (K Units)
Table 42. APAC Trastuzumab Biosimilar Sales Market Share by Region (2018-2023)
Table 43. APAC Trastuzumab Biosimilar Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Trastuzumab Biosimilar Revenue Market Share by Region (2018-2023)
Table 45. APAC Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 46. APAC Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 47. Europe Trastuzumab Biosimilar Sales by Country (2018-2023) & (K Units)
Table 48. Europe Trastuzumab Biosimilar Sales Market Share by Country (2018-2023)
Table 49. Europe Trastuzumab Biosimilar Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Trastuzumab Biosimilar Revenue Market Share by Country (2018-2023)
Table 51. Europe Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 52. Europe Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Trastuzumab Biosimilar Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Trastuzumab Biosimilar Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Trastuzumab Biosimilar Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Trastuzumab Biosimilar Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Trastuzumab Biosimilar Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Trastuzumab Biosimilar
Table 60. Key Market Challenges & Risks of Trastuzumab Biosimilar
Table 61. Key Industry Trends of Trastuzumab Biosimilar
Table 62. Trastuzumab Biosimilar Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Trastuzumab Biosimilar Distributors List
Table 65. Trastuzumab Biosimilar Customer List
Table 66. Global Trastuzumab Biosimilar Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Trastuzumab Biosimilar Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Trastuzumab Biosimilar Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Trastuzumab Biosimilar Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Trastuzumab Biosimilar Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Trastuzumab Biosimilar Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Trastuzumab Biosimilar Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Trastuzumab Biosimilar Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Trastuzumab Biosimilar Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Trastuzumab Biosimilar Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Trastuzumab Biosimilar Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Trastuzumab Biosimilar Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Trastuzumab Biosimilar Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Trastuzumab Biosimilar Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Amgen Inc. Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 81. Amgen Inc. Trastuzumab Biosimilar Product Portfolios and Specifications
Table 82. Amgen Inc. Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Amgen Inc. Main Business
Table 84. Amgen Inc. Latest Developments
Table 85. Pfizer Inc Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 86. Pfizer Inc Trastuzumab Biosimilar Product Portfolios and Specifications
Table 87. Pfizer Inc Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Pfizer Inc Main Business
Table 89. Pfizer Inc Latest Developments
Table 90. Samsung Bioepis Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 91. Samsung Bioepis Trastuzumab Biosimilar Product Portfolios and Specifications
Table 92. Samsung Bioepis Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Samsung Bioepis Main Business
Table 94. Samsung Bioepis Latest Developments
Table 95. Merck & Co. Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 96. Merck & Co. Trastuzumab Biosimilar Product Portfolios and Specifications
Table 97. Merck & Co. Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Merck & Co. Main Business
Table 99. Merck & Co. Latest Developments
Table 100. Biocon Limited Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 101. Biocon Limited Trastuzumab Biosimilar Product Portfolios and Specifications
Table 102. Biocon Limited Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Biocon Limited Main Business
Table 104. Biocon Limited Latest Developments
Table 105. Teva Pharmaceutical Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 106. Teva Pharmaceutical Trastuzumab Biosimilar Product Portfolios and Specifications
Table 107. Teva Pharmaceutical Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Teva Pharmaceutical Main Business
Table 109. Teva Pharmaceutical Latest Developments
Table 110. Genentech Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 111. Genentech Trastuzumab Biosimilar Product Portfolios and Specifications
Table 112. Genentech Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Genentech Main Business
Table 114. Genentech Latest Developments
Table 115. Mundipharma Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 116. Mundipharma Trastuzumab Biosimilar Product Portfolios and Specifications
Table 117. Mundipharma Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Mundipharma Main Business
Table 119. Mundipharma Latest Developments
Table 120. Celltrion Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 121. Celltrion Trastuzumab Biosimilar Product Portfolios and Specifications
Table 122. Celltrion Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Celltrion Main Business
Table 124. Celltrion Latest Developments
Table 125. Henlius Basic Information, Trastuzumab Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 126. Henlius Trastuzumab Biosimilar Product Portfolios and Specifications
Table 127. Henlius Trastuzumab Biosimilar Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Henlius Main Business
Table 129. Henlius Latest Developments
LIST OF FIGURES
Figure 1. Picture of Trastuzumab Biosimilar
Figure 2. Trastuzumab Biosimilar Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Trastuzumab Biosimilar Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Trastuzumab Biosimilar Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Trastuzumab Biosimilar Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adjuvant Breast Cancer
Figure 10. Product Picture of Metastatic Breast Cancer
Figure 11. Product Picture of Metastatic Gastric Cancer
Figure 12. Product Picture of Others
Figure 13. Global Trastuzumab Biosimilar Sales Market Share by Type in 2022
Figure 14. Global Trastuzumab Biosimilar Revenue Market Share by Type (2018-2023)
Figure 15. Trastuzumab Biosimilar Consumed in Hospital Pharmacy
Figure 16. Global Trastuzumab Biosimilar Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 17. Trastuzumab Biosimilar Consumed in Online Pharmacy
Figure 18. Global Trastuzumab Biosimilar Market: Online Pharmacy (2018-2023) & (K Units)
Figure 19. Global Trastuzumab Biosimilar Sales Market Share by Application (2022)
Figure 20. Global Trastuzumab Biosimilar Revenue Market Share by Application in 2022
Figure 21. Trastuzumab Biosimilar Sales Market by Company in 2022 (K Units)
Figure 22. Global Trastuzumab Biosimilar Sales Market Share by Company in 2022
Figure 23. Trastuzumab Biosimilar Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Trastuzumab Biosimilar Revenue Market Share by Company in 2022
Figure 25. Global Trastuzumab Biosimilar Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Trastuzumab Biosimilar Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 28. Americas Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 29. APAC Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 30. APAC Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 31. Europe Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 32. Europe Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 35. Americas Trastuzumab Biosimilar Sales Market Share by Country in 2022
Figure 36. Americas Trastuzumab Biosimilar Revenue Market Share by Country in 2022
Figure 37. Americas Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 38. Americas Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 39. United States Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Trastuzumab Biosimilar Sales Market Share by Region in 2022
Figure 44. APAC Trastuzumab Biosimilar Revenue Market Share by Regions in 2022
Figure 45. APAC Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 46. APAC Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 47. China Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Trastuzumab Biosimilar Sales Market Share by Country in 2022
Figure 55. Europe Trastuzumab Biosimilar Revenue Market Share by Country in 2022
Figure 56. Europe Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 57. Europe Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 58. Germany Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Trastuzumab Biosimilar Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 67. Egypt Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Trastuzumab Biosimilar in 2022
Figure 73. Manufacturing Process Analysis of Trastuzumab Biosimilar
Figure 74. Industry Chain Structure of Trastuzumab Biosimilar
Figure 75. Channels of Distribution
Figure 76. Global Trastuzumab Biosimilar Sales Market Forecast by Region (2024-2029)
Figure 77. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Trastuzumab Biosimilar Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Trastuzumab Biosimilar Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Trastuzumab Biosimilar
Figure 2. Trastuzumab Biosimilar Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Trastuzumab Biosimilar Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Trastuzumab Biosimilar Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Trastuzumab Biosimilar Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Adjuvant Breast Cancer
Figure 10. Product Picture of Metastatic Breast Cancer
Figure 11. Product Picture of Metastatic Gastric Cancer
Figure 12. Product Picture of Others
Figure 13. Global Trastuzumab Biosimilar Sales Market Share by Type in 2022
Figure 14. Global Trastuzumab Biosimilar Revenue Market Share by Type (2018-2023)
Figure 15. Trastuzumab Biosimilar Consumed in Hospital Pharmacy
Figure 16. Global Trastuzumab Biosimilar Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 17. Trastuzumab Biosimilar Consumed in Online Pharmacy
Figure 18. Global Trastuzumab Biosimilar Market: Online Pharmacy (2018-2023) & (K Units)
Figure 19. Global Trastuzumab Biosimilar Sales Market Share by Application (2022)
Figure 20. Global Trastuzumab Biosimilar Revenue Market Share by Application in 2022
Figure 21. Trastuzumab Biosimilar Sales Market by Company in 2022 (K Units)
Figure 22. Global Trastuzumab Biosimilar Sales Market Share by Company in 2022
Figure 23. Trastuzumab Biosimilar Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Trastuzumab Biosimilar Revenue Market Share by Company in 2022
Figure 25. Global Trastuzumab Biosimilar Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Trastuzumab Biosimilar Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 28. Americas Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 29. APAC Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 30. APAC Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 31. Europe Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 32. Europe Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Trastuzumab Biosimilar Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Trastuzumab Biosimilar Revenue 2018-2023 ($ Millions)
Figure 35. Americas Trastuzumab Biosimilar Sales Market Share by Country in 2022
Figure 36. Americas Trastuzumab Biosimilar Revenue Market Share by Country in 2022
Figure 37. Americas Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 38. Americas Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 39. United States Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Trastuzumab Biosimilar Sales Market Share by Region in 2022
Figure 44. APAC Trastuzumab Biosimilar Revenue Market Share by Regions in 2022
Figure 45. APAC Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 46. APAC Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 47. China Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Trastuzumab Biosimilar Sales Market Share by Country in 2022
Figure 55. Europe Trastuzumab Biosimilar Revenue Market Share by Country in 2022
Figure 56. Europe Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 57. Europe Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 58. Germany Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Trastuzumab Biosimilar Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Trastuzumab Biosimilar Sales Market Share by Application (2018-2023)
Figure 67. Egypt Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Trastuzumab Biosimilar Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Trastuzumab Biosimilar in 2022
Figure 73. Manufacturing Process Analysis of Trastuzumab Biosimilar
Figure 74. Industry Chain Structure of Trastuzumab Biosimilar
Figure 75. Channels of Distribution
Figure 76. Global Trastuzumab Biosimilar Sales Market Forecast by Region (2024-2029)
Figure 77. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Trastuzumab Biosimilar Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Trastuzumab Biosimilar Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Application (2024-2029)
